Lineage Cell Therapeutics
LCTX
#8761
Rank
ยฃ0.18 B
Marketcap
ยฃ0.72
Share price
-4.01%
Change (1 day)
-45.66%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2026 (TTM): -ยฃ20.15 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are ยฃ13.08 Million. In 2025 the company made an earning of -ยฃ16.47 Million a decrease over its 2024 earnings that were of -ยฃ16.24 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ20.15 Million22.35%
2025 -ยฃ16.47 Million1.4%
2024 -ยฃ16.24 Million-13.16%
2023 -ยฃ18.7 Million9.83%
2022 -ยฃ17.03 Million-54.24%
2021 -ยฃ37.21 Million86.07%
2020 -ยฃ20 Million-31.97%
2019 -ยฃ29.4 Million-5.42%
2018 -ยฃ31.08 Million1.1%
2017 -ยฃ30.74 Million-31.06%
2016 -ยฃ44.59 Million-10.38%
2015 -ยฃ49.76 Million29.69%
2014 -ยฃ38.37 Million31.68%
2013 -ยฃ29.14 Million
2011 -ยฃ14.14 Million89.78%
2010 -ยฃ7.45 Million206.06%
2009 -ยฃ2.44 Million-0.58%
2008 -ยฃ2.45 Million164.89%
2007 -ยฃ0.93 Million-30.22%
2006 -ยฃ1.33 Million
2002 -ยฃ1.54 Million-41.04%
2001 -ยฃ2.61 Million-32.04%
2000 -ยฃ3.84 Million-11.85%
1999 -ยฃ4.36 Million
1997 -ยฃ2.8 Million12.12%
1996 -ยฃ2.5 Million106.25%
1995 -ยฃ1.21 Million-11.11%
1994 -ยฃ1.37 Million50%
1993 -ยฃ0.91 Million20%
1992 -ยฃ0.76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-ยฃ0.12 Billion 481.52%๐Ÿ‡บ๐Ÿ‡ธ USA